Introduction {#sec1-1}
============

**What was known?**

Till date to our knowledge and available literature only three cases of lymphangiosarcoma arising in post filarial lymphedema have been reported.

Cutaneous angiosarcoma is an uncommon aggressive tumor of the capillary and lymphatic endothelial cell origin. Post mastectomy chronic lymphedema is the most frequent setting in which lymphedema related lymphangiosarcoma develops.\[[@ref1]\] Though this tumor has also been described in traumatic, post surgical and congenital lymphedema, it has been encountered in patients with filarial lymphedema very rarely.

We are reporting a case of lymphangiosarcoma developing in a 36 year old female who had a past history of filariasis since 20 years.

Case Report {#sec1-2}
===========

A 36 year old female patient had bilateral lymphedema following filarial infection since 20 yrs. She came with a complaint of fungating mass on left leg. To start with it was reddish nodule which progressed into a fungating mass within a span of 4 months.

On physical examination patient had extensive skin thickening and an fungating soft tissue mass measuring 10 cm × 7 cm in the medial aspect of the left leg \[[Figure 1](#F1){ref-type="fig"}\].

![Clinical photograph of patient with bilateral lymphedema (a) and left leg fungating mass (b)](IJD-58-68-g001){#F1}

A skin biopsy was performed which showed a tumor composed of numerous pleomorphic spindle cells lining the anastomozing blood vessels \[[Figure 2](#F2){ref-type="fig"}\]. Focal areas of dystrophic calcification in the form of calcosphere were seen consistent with old filarial infection. On immunohistochemistry, tumor cells were positive for CD34, CD31, vimentin, and negative for Cytokeratin (CK) which confirmed our diagnosis of angiosarcoma.

![Photomicrograph showing numerous pleomorphic spindle cells lining anastomozing blood Vessels with overlying skin (H and E) ×100 (a) and ×400 (b and c)](IJD-58-68-g002){#F2}

Patient undergone below knee amputation without any adjuvant therapy. The follow up of the patient till date show no evidence of recurrence or metastasis.

Discussion {#sec1-3}
==========

Angiosarcoma can develop from the endothelium of lymphatics (lymphangiosarcoma) or blood vessels (hemangiosarcoma). This subclassification is often very difficult to make, however, since there apparently is no difference in the clinical activity.\[[@ref2]\]

Stewart and Terres in 1948 were the first to describe a cases of lymphangiosarcoma arising in a case of post mastectomy chronic lymphedema.\[[@ref3]\] In a review of lymphangiosarcoma arising in a setting of chronic lymphedema in 1972.\[[@ref4]\] infectious causes for the tumor was implicated in only two cases of which one was tuberculosis and the other unknown \[[Table 1](#T1){ref-type="table"}\].

###### 

Cases of lymphangiosarcoma reported after filariasis

![](IJD-58-68-g003)

In our case, patient gave history of chronic filarial infection in past with subsequent development of bilateral lymphedema 20 year back. There was no history of leg or groin trauma, surgery, radiation or lymphadenopathy before development of lymphedema.

We found few foci of dystrophic calcospheres spread within the lesion which represents mineralized degenerated worms\[[@ref5]\] Although we did not identify the viable parasite, the patient\'s history and tissue diagnosis is suggestive of chronic filarial infection.

Filariasis which is endemic in our country often leads to lymphedema. In a review of large cases of filarial lymphedema in 1966, El Toraei\[[@ref6]\] did not identify a single case of lymphangiosaroma associated with filaria.

Devi and Bahuleyan (1977)\[[@ref1]\] were the first to report a case of lymphangiosarcoma of the lower extremity associated with chronic lymphedema of filarial origin.

They attributed chronic lymph stasis as the underlying mechanism for this neoplasm.

Till date to our knowledge and available literature only three cases of lymphangiosarcoma arising in post filarial lymphedema have been reported.

In all the cases, the lower limb was affected and lymphangiosarcoma developed after lymphedema of many years duration. The tumors were in the form of large cutaneous and soft tissue masses.

The exact pathogenesis of angiosarcoma in these cases is uncertain. It has been shown in animal models that the environment produced by longstanding lymphedema is conducive to atypical vascular proliferation, with mutations eventually leading to malignant transformation of the endothelial cells. Alternatively, the lymphedema may impair local immunity, preventing immune detection and destruction of the malignant-tumor cells.\[[@ref2]\]

The natural history of angiosarcoma associated with chronic lymphedema is repeated recurrence and eventual metastasis, usually to the lungs. The clinical outcome is poor, with less than 10 percent of the patients surviving longer than five years after the diagnosis. The recommended treatment for a tumor of this type in an extremity is amputation, with or without radiation therapy and chemotherapy.\[[@ref8][@ref9]\]

Conclusions {#sec1-4}
===========

Lymphangiosarcoma developing in a setting of filarial lymphedema is very rare.Patients whose lynmphangiosarcoma is associated with filarial lymphedema in endemic areas may go unnoticed and undiagnosed due to lack of recognition and proper medial care.Even though the number of cases is small and the follow up is limited, it seems that lymphangiosarcoma developing in the background of filarial lymphedema remains localized for relatively long periods.Therefore, more cases must be studied to understand the behavior of lymphangiosarcoma in this particular setting.

**What is new?**

The exact pathogenesis of angiosarcoma in these cases is uncertain. It has been shown in animal models that the environment produced by longstanding lymphedema is conducive to atypical vascular proliferation, with mutations eventually leading to malignant transformation of the endothelial cells. The clinical outcome is poor, with less than 10 percent of the patients surviving longer than five years after the diagnosis
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